It encodes two distinct tumor suppressors, namely p16INK4A and p14ARF, which positively regulate retinoblastoma (RB) and p53 pivotal tumor suppressors (by inactivating MDM2), respectively [113]. The gene discussed is CDKN2A; the disease is neoplasm.